finasteride has been researched along with Adverse Drug Event in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bauer, SR; Covinsky, K; Ensrud, KE; Liu, TT; McVary, KT; Newman, JC; Ricke, WA; Suskind, AM; Walter, LC | 1 |
| Alnajjar, HM; Boeri, L; Cakir, OO; Capogrosso, P; Castiglione, F; Chiappini, S; Deho', F; Fallara, G; Harvey, H; Montorsi, F; Muneer, A; Rewhorn, M; Salonia, A; Schifano, F; Schifano, N | 1 |
| Bonaventura, I; Cornfield, T; Duffy, J; Hazlehurst, JM; Hodson, L; Isidori, AM; Marjot, T; Moolla, A; Nikolaou, N; Othonos, N; Pofi, R; Tomlinson, JW; Webster, C; White, S; Woods, C | 1 |
| Borgo, F; Cavaletti, G; Diviccaro, S; Falvo, E; Giatti, S; Macandog, AD; Melcangi, RC | 1 |
| Kajdy, A; Maksym, RB; Rabijewski, M | 1 |
| Cauci, S; Cecchin, E; De Mattia, E; Mazzon, G; Toffoli, G; Trombetta, C | 1 |
| Ganzer, CA; Jacobs, AR | 1 |
| Baconi, D; Balalau, C; Baleanu, BC; Constantin, V; Georgescu, SR; Motofei, IG; Paunica, S; Rowland, DL; Stefanescu, E; Tampa, M | 1 |
| Li, Q; Wu, M; Yu, Q | 1 |
| Bergstrom, KG | 1 |
1 review(s) available for finasteride and Adverse Drug Event
| Article | Year |
|---|---|
Post-finasteride syndrome - does it really exist?
Topics: 5-alpha Reductase Inhibitors; Alopecia; Drug-Related Side Effects and Adverse Reactions; Finasteride; Humans; Iatrogenic Disease; Male; Prostatic Hyperplasia; Quality of Life; Sexual Dysfunction, Physiological | 2019 |
1 trial(s) available for finasteride and Adverse Drug Event
| Article | Year |
|---|---|
Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids.
Topics: 5-alpha Reductase Inhibitors; Adipose Tissue; Adolescent; Adult; Aged; Disease Progression; Drug Interactions; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Dutasteride; Energy Metabolism; Finasteride; Glucocorticoids; Glucose Clamp Technique; Healthy Volunteers; Humans; Male; Middle Aged; Prednisolone; Prescription Drugs; Proof of Concept Study; Young Adult | 2020 |
12 other study(ies) available for finasteride and Adverse Drug Event
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Assessment of Frailty and Association With Progression of Benign Prostatic Hyperplasia Symptoms and Serious Adverse Events Among Men Using Drug Therapy.
Topics: Aged; Aged, 80 and over; Disease Progression; Doxazosin; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Finasteride; Follow-Up Studies; Frail Elderly; Frailty; Geriatric Assessment; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Proportional Hazards Models; Prostatic Hyperplasia; Severity of Illness Index; Urological Agents | 2021 |
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovi
Topics: Adverse Drug Reaction Reporting Systems; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Finasteride; Humans; Male; Penile Diseases; Penile Induration; Pharmacovigilance; United States; United States Food and Drug Administration | 2023 |
Alterations of gut microbiota composition in post-finasteride patients: a pilot study.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Biodiversity; Cognitive Dysfunction; Correlation of Data; Depression; Drug-Related Side Effects and Adverse Reactions; Finasteride; Gastrointestinal Microbiome; Humans; Male; Middle Aged; Physical Functional Performance; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sexual Dysfunction, Physiological | 2021 |
A pharmacogenetic survey of androgen receptor (CAG)n and (GGN)n polymorphisms in patients experiencing long term side effects after finasteride discontinuation.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Drug-Related Side Effects and Adverse Reactions; Finasteride; Genetic Predisposition to Disease; Humans; Male; Pharmacogenetics; Polymorphism, Single Nucleotide; Prostatic Hyperplasia; Receptors, Androgen; Retrospective Studies; Surveys and Questionnaires | 2014 |
Emotional Consequences of Finasteride: Fool's Gold.
Topics: Adult; Age Factors; Alopecia; Anxiety; Cross-Sectional Studies; Depression; Drug-Related Side Effects and Adverse Reactions; Emotions; Female; Finasteride; Humans; Incidence; Male; Patient Reported Outcome Measures; Pharmacovigilance; Risk Assessment; Sex Factors; Surveys and Questionnaires; Syndrome; United States; Young Adult | 2018 |
Finasteride adverse effects in subjects with androgenic alopecia: A possible therapeutic approach according to the lateralization process of the brain.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Brain; Drug-Related Side Effects and Adverse Reactions; Finasteride; Functional Laterality; Humans; Male; Risk Factors; Sexual Behavior | 2016 |
Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases.
Topics: 5-alpha Reductase Inhibitors; Adverse Drug Reaction Reporting Systems; Alopecia; Drug-Related Side Effects and Adverse Reactions; Female; Fetus; Finasteride; Gene Expression Regulation; Gene Regulatory Networks; Hair; Humans; Male; Minoxidil; Reproduction; Risk Assessment; Risk Factors; Sex Factors; United States; United States Food and Drug Administration; Uterus | 2016 |
What's new in androgenetic alopecia: approvals, long-term safety data, cancer risk and treatment options for women.
Topics: Alopecia; Azasteroids; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Dutasteride; Female; Finasteride; Humans; Male; Minoxidil; Neoplasms; Risk Factors; Time Factors | 2011 |